Compare TNYA & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNYA | NIU |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | China |
| Employees | N/A | 671 |
| Industry | Medicinal Chemicals and Botanical Products | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.5M | 200.8M |
| IPO Year | 2021 | 2018 |
| Metric | TNYA | NIU |
|---|---|---|
| Price | $0.78 | $2.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $5.33 | $3.50 |
| AVG Volume (30 Days) | ★ 2.4M | 315.3K |
| Earning Date | 05-07-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.96 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $25.54 |
| Revenue Next Year | N/A | $17.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $1.93 |
| 52 Week High | $2.35 | $5.67 |
| Indicator | TNYA | NIU |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 60.69 |
| Support Level | $0.65 | $2.31 |
| Resistance Level | $0.80 | $3.24 |
| Average True Range (ATR) | 0.06 | 0.14 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 13.25 | 72.11 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Niu Technologies designs, manufactures, and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycles, mopeds, and bicycle series, including the NQi, MQi, UQi, FQi series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.